Daily aspirin is not recommended for most people without existing heart disease due to bleeding risks; the decision requires an individual doctor’s assessment..
You’ve probably heard the old advice: pop a baby aspirin every day to keep your heart safe. For decades, that was standard wisdom. Many people started the habit on their own, figuring a little blood thinner couldn’t hurt.
The science has shifted sharply. Major guidelines now say daily aspirin for heart disease prevention carries real bleeding risks that can outweigh the benefits for most people. The honest answer to whether you should take it depends on your age, your cardiovascular risk profile, and your bleeding risk — not on a one-size-fits-all rule.
Why The Advice Changed So Dramatically
For years, aspirin’s ability to make blood less sticky and reduce clotting seemed like a straightforward win for heart attack and stroke prevention. The mechanism still works — low-dose aspirin is an antiplatelet therapy drug that protects against atherothrombosis.
But large trials changed the picture. The ASPREE trial, published in the New England Journal of Medicine, found that older adults taking daily aspirin had a significantly higher risk of major hemorrhage without a corresponding drop in cardiovascular events. That finding forced a major rethink.
The U.S. Preventive Services Task Force updated its guidelines in 2022. For adults 60 or older, the USPSTF now recommends against starting low-dose aspirin for primary prevention — meaning no prior heart attack or stroke. The bleeding risk simply outweighs the benefit at that age.
Who Daily Aspirin Might Still Help
The updated guidelines don’t say aspirin is useless. They say it’s useful for a much narrower group than previously assumed. If you’re in the right category, it may still make sense.
- Age 40 to 59 with elevated risk: If your 10-year cardiovascular disease risk is 10% or greater, the decision should be individual. The net benefit is small, but for some people it tips in favor of aspirin.
- No elevated bleeding risk: People with a history of stomach ulcers, kidney issues, or bleeding disorders should generally avoid aspirin. Those without such risks are better candidates for a discussion.
- Secondary prevention (different rules): If you’ve already had a heart attack, stroke, or stent placement, daily aspirin is well-established and recommended. That’s secondary prevention, and the evidence supporting it remains strong.
- Doctor-supervised only: The American Heart Association states clearly that you should not take daily low-dose aspirin without talking to your primary health care professional first.
Notice what’s not on that list: age 70 or older. For adults over 70 without prior cardiovascular disease, the consensus across major organizations is that the bleeding risks outweigh any potential benefit.
Understanding Your Bleeding Risk
Aspirin doesn’t just gently thin the blood. It interferes with the clotting process, which can have serious consequences. The primary concerns are gastrointestinal bleeding and intracranial hemorrhage — bleeding inside the skull. These aren’t rare theoretical risks.
A 2019 meta-analysis published in JAMA found that aspirin use was associated with a reduction in the primary cardiovascular composite outcome but also with increases in major bleeding in both low and intermediate risk groups. The trade-off was real in every risk category studied. To see how your personal profile fits the current evidence, talking with your doctor about your specific risk factors.
Your doctor can calculate your 10-year ASCVD risk using factors like age, cholesterol levels, blood pressure, smoking status, and diabetes. That score helps determine whether the small cardiovascular benefit of aspirin is worth the bleeding risk for you.
| Age Group | Primary Prevention Recommendation | Key Risk Factor |
|---|---|---|
| Under 40 | Not recommended; insufficient evidence | Low baseline risk |
| 40 to 59 (high risk) | Individual decision; small net benefit | Bleeding history matters |
| 60 to 69 | Generally not recommended (USPSTF) | Bleeding risk increases with age |
| 70 and older | Recommended against; risks outweigh benefits | ASPREE trial confirmed higher hemorrhage risk |
| Any age (secondary prevention) | Well-established; recommended | Prior heart attack or stroke |
The table shows how age and prior history can shift the recommendation. The same 81 mg pill that helps one person may harm another.
How To Have The Conversation With Your Doctor
If you’re currently taking daily aspirin without a doctor’s recommendation, or if you’re considering starting, the next step is a specific informed conversation. Here’s what to bring up.
- Ask for your 10-year ASCVD risk score. Your doctor can calculate this from a simple blood panel and blood pressure reading. The result tells you whether you’re in the 10% or greater risk category where aspirin might be considered.
- Discuss your bleeding risk factors. Mention any history of ulcers, easy bruising, nosebleeds, kidney disease, or use of other blood thinners like ibuprofen, naproxen, or prescription anticoagulants.
- Be honest about self-medication. Many people start taking baby aspirin on their own. Tell your doctor directly so they can factor it into your overall medication profile.
Your doctor may calculate your risk, weigh your bleeding history, and conclude aspirin is appropriate — or they may recommend other strategies like statins, blood pressure control, or lifestyle changes instead. Either way, the decision should be documented in your chart.
What The Latest Data Shows
The shift against routine aspirin use for primary prevention isn’t just one organization’s opinion. It’s supported by consistent findings across multiple large trials and major medical societies. A 2022 review in PMC concluded that low-dose aspirin is not recommended on a routine basis for primary prevention in adults older than 70 or among those with increased bleeding risk.
A 2024 study in Blood Advances confirmed that recent guidelines have recommended a reduced role for primary prevention aspirin due to bleeding risk. The Mayo Clinic notes that daily aspirin therapy is well-established for secondary prevention but warns that the benefits for primary prevention are smaller than once thought.
The consistency across sources — USPSTF, American Heart Association, American College of Cardiology, Mayo Clinic, UCLA Health, and the NHS — gives high confidence that this is a genuine evidence shift, not a passing trend. The standard daily dose of 81 mg remains the same; the population it’s recommended for has narrowed significantly.
| Source | Position on Primary Prevention |
|---|---|
| USPSTF (2022) | Against for ages 60+; individual decision for ages 40-59 with ≥10% risk |
| American Heart Association | Do not take without talking to your doctor |
| American College of Cardiology | May be considered for select adults 40-70 with higher ASCVD risk, no bleeding risk |
| NHS | Daily low-dose aspirin helps prevent heart attacks, but only on a doctor’s advice |
The Bottom Line
Daily aspirin for heart health is not the no-brainer it used to be. For most people without heart disease, especially those over 60 or with bleeding risks, the risks outweigh the benefits. For a narrower group — ages 40 to 59 with elevated cardiovascular risk and no bleeding history — it may be worth a careful conversation. The key is that you shouldn’t decide alone.
A primary care physician or cardiologist can calculate your 10-year risk score, review your bleeding history, and determine whether the small potential reduction in heart attack and stroke risk is worth taking on the real possibility of gastrointestinal or intracranial bleeding.
References & Sources
- Health. “Talk Your Doctor About Taking Aspirin Prevent Heart Disease” The U.S. Department of Health and Human Services recommends talking with your doctor about taking aspirin to prevent heart disease, noting that taking aspirin so often has health.
- Mayo Clinic. “Art 20046797” The standard daily dose for low-dose aspirin therapy is 75 mg to 100 mg, with 81 mg being the most common dose in the U.S.
Mo Maruf
I created WellFizz to bridge the gap between vague wellness advice and actionable solutions. My mission is simple: to decode the research and give you practical tools you can actually use.
Beyond the data, I am a passionate traveler. I believe that stepping away from the screen to explore new environments is essential for mental clarity and physical vitality.